Could oxytocin reduce autoimmune disease in COVID-19?

Autoimmun Rev

Ministère de l'Enseignement Supérieur, de la Recherche et de l'innovation, Paris, France.

Published: February 2022

Disruption of immune and neuroendocrine system function has been shown to play a key role in COVID-19. Oxytocin is vitally important for the immune and neuroendocrine systems. However, oxytocin dysfunction might occur in COVID-19 leading to autoimmune disease. Intranasal oxytocin may be effective in turning off an overactive immune system. This could be a powerful approach to avoid possible autoimmune diseases after COVID-19.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592845PMC
http://dx.doi.org/10.1016/j.autrev.2021.102994DOI Listing

Publication Analysis

Top Keywords

autoimmune disease
8
immune neuroendocrine
8
oxytocin
4
oxytocin reduce
4
reduce autoimmune
4
disease covid-19?
4
covid-19? disruption
4
disruption immune
4
neuroendocrine system
4
system function
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!